WHO recognises 'concerning news' of COVID-19 vaccines not working against variants

Booster shots will likely be needed, since new virus variants are spreading globally and likely to become the predominant strains.

The Associated Press February 09, 2021 09:37:31 IST
WHO recognises 'concerning news' of COVID-19 vaccines not working against variants

Most vaccines against the coronavirus are targetting the spike protein on the virus – which we know from older viruses and studies, is also a target for the immune system. Image: Wikimedia Commons

The head of the World Health Organization said Monday the emergence of new COVID-19 variants has raised questions about whether or not existing vaccines will work, calling it "concerning news" that the vaccines developed so far may be less effective against the variant first detected in South Africa. Tedros Adhanom Ghebreyesus said at a media briefing that South Africa’s decision on Sunday to suspend its vaccination campaign using the AstraZeneca vaccine is “a reminder that we need to do everything we can to reduce circulation of the virus with proven public health measures.”

He said it was increasingly clear that vaccine manufacturers would need to tweak their existing shots to address the ongoing genetic evolution of the coronavirus , saying booster shots would most likely be necessary, especially since new variants of the virus are now spreading globally and appear likely to become the predominant strains.

Tedros added that WHO expected to make a decision “in the next few days” on whether it would recommend an emergency use listing for the AstraZeneca vaccine. That designation would allow millions of doses to be shipped to poor countries as part of a UN-backed effort to distribute COVID-19 vaccines worldwide known as COVAX.

Last week, Tedros said that more than three quarters of COVID-19 vaccines had been administered in just 10 countries and that immunization in nearly 130 countries had yet to start. Despite WHO’s aim of starting COVID-19 vaccination in poor countries at the same time as wealthy countries, COVAX hasn’t delivered any vaccine doses anywhere.

Dr Soumya Swaminathan, WHO’s chief scientist, said people shouldn’t conclude from South Africa’s decision that the AstraZeneca vaccine doesn’t work. She said all of the available evidence to date shows the vaccines developed so far reduce deaths, hospitalizations and severe disease.

Other COVID-19 vaccines developed by Novavax, Pfizer and BioNTech and Johnson & Johnson also appear to be less effective against the strain first identified in South Africa, although they may prevent severe disease.

Updated Date:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

Ghana becomes first African country to receive COVID-19 vaccines from the COVAX alliance
science

Ghana becomes first African country to receive COVID-19 vaccines from the COVAX alliance

Ghana's food and drug authority has already authorised the use of the Indian-made vaccines as well as Russia's Sputnik V.

Johnson & Johnson’s COVID-19 vaccine differs considerably from Pfizer’s, Moderna’s
World

Johnson & Johnson’s COVID-19 vaccine differs considerably from Pfizer’s, Moderna’s

JnJ's vaccine appears to be less prone than Pfizer-BioNTech's and Moderna's, to trigger the kinds of side effects that require monitoring.

First dose of Pfizer, AstraZeneca shots cut transmission, hospitalisation risk, say UK studies
World

First dose of Pfizer, AstraZeneca shots cut transmission, hospitalisation risk, say UK studies

Being the first nation to begin mass vaccinations in December, over 17 million UK resident have received at least a first dose so far.